Status:
TERMINATED
Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Kidney Transplant Recipients
Eligibility:
All Genders
18+ years
Brief Summary
The investigators goal is to assess the vaccine response of kidney transplant patients following vaccination against SARS-CoV-2. The study population will be derived from cohorts of kidney transplant...
Eligibility Criteria
Inclusion
- Male or female, 18 years of age or older
- Patient vaccinated against SARS-CoV-2 as part of routine care
- Kidney or pancreatic kidney transplant
- Transplantation for more than 3 months
- Subject affiliated to a social protection health insurance
- Subject able to understand the objectives and risks of the research and to give signed and dated informed consent
Exclusion
- History of anaphylactic shock or known allergy to PEG
- Known history of COVID or positive Covid serology in the 3 months prior to vaccination
- Contraindication to an intramuscular injection
- Impossibility to give informed information about the subject (subject in an emergency situation, difficulties in understanding the subject, ...)
- Subject under safeguard of justice
- Subject under guardianship
Key Trial Info
Start Date :
February 2 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT04757883
Start Date
February 2 2021
End Date
November 1 2024
Last Update
August 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Caillard Sophie
Strasbourg, France, 67000